TRDA logo

Entrada Therapeutics, Inc.

TRDA
Healthcare|Biotechnology|US
$4.89
+0.34 (+7.47%)
DCF Value
$9.63
Tangible Book / Share
$4.68
Cash / Share
$4.56

Ownership Breakdown

58.2%
Float
38.9M
Shares Outstanding
22.7M
Float Shares

Major Holders (29)

Combined: 147.1%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Kush ParmarIndividual10.80%4,123,849Nov 18, 202513D/G
Andrew J. SchwabIndividual10.60%4,056,379Nov 18, 202513D/G
Todd FoleyIndividual9.90%3,885,115Sep 10, 202613D/G
Ansbert GadickeIndividual9.90%3,885,115Sep 10, 202613D/G
Luke EvninIndividual9.90%3,885,115Sep 10, 202613D/G
5AM Partners V, LLCOther7.80%2,963,066Nov 18, 202513D/G
5AM Ventures V, L.P.Partnership7.80%2,963,066Nov 18, 202513D/G
Scott M. RocklageIndividual7.80%2,963,066Nov 18, 202513D/G
Roche Holding LtdCorporation6.90%2,569,115Feb 14, 202513D/G
Roche Finance LtdCorporation6.90%2,569,115Feb 14, 202513D/G
BlackRock, Inc.Holding company5.30%1,974,452Feb 4, 202513D/G
MPM BioVentures 2014 LLCOther5.00%1,942,556Sep 10, 202613D/G
MPM BioVentures 2018 LLCOther5.00%1,942,559Sep 10, 202613D/G
Janus Henderson Biotech Innovation Master Fund LtdInvestment company5.00%1,884,826May 14, 202513D/G
MPM BioVentures 2018 GP LLCOther4.90%1,906,824Sep 10, 202613D/G
MPM BioVentures 2014 GP LLCOther4.80%1,881,834Sep 10, 202613D/G
MPM Bioventures 2018, L.P.Partnership4.70%1,810,592Sep 10, 202613D/G
MPM BioVentures 2014, L.P.Partnership4.50%1,764,167Sep 10, 202613D/G
Janus Henderson Group PLCIA, HC4.00%1,521,281Aug 14, 202513D/G
5AM Opportunities I (GP), LLCOther2.90%0Nov 18, 202513D/G
5AM Opportunities I, L.P.Partnership2.90%1,093,313Nov 18, 202513D/G
TCG Crossover GP I, LLCOther2.70%1,060,230Aug 14, 202613D/G
Chen YuIndividual2.70%1,060,230Aug 14, 202613D/G
TCG Crossover Fund I, L.P.Partnership2.70%1,060,230Aug 14, 202613D/G
T. Rowe Price Associates, Inc.Investment adviser0.90%360,526Nov 14, 202513D/G
MPM BioVentures 2014 (B), L.P.Partnership0.30%117,667Sep 10, 202613D/G
MPM Asset Management Investors BV2014 LLCOther0.20%60,722Sep 10, 202613D/G
MPM Bioventures 2018 (B), L.P.Partnership0.20%96,232Sep 10, 202613D/G
MPM Asset Management Investors BV2018 LLCOther0.10%35,735Sep 10, 202613D/G

Insider Trades (100)

Last 4 quarters: 1,077,511 acquired · 2,035,201 disposed
InsiderPositionDateTypeSharesPriceValueFiling
MPM BIOVENTURES 2018, L.P.10 percent ownerSep 4, 2026SELL38,500$7.11$273.7KForm 4
MPM BIOVENTURES 2018, L.P.10 percent ownerSep 8, 2026SELL192,500$7.41$1.4MForm 4
MPM BIOVENTURES 2018, L.P.10 percent ownerSep 9, 2026SELL28,837$7.13$205.6KForm 4
MPM BioVentures 2014, L.P.10 percent ownerSep 4, 2026SELL38,500$7.11$273.7KForm 4
MPM BioVentures 2014, L.P.10 percent ownerSep 8, 2026SELL192,500$7.41$1.4MForm 4
MPM BioVentures 2014, L.P.10 percent ownerSep 9, 2026SELL28,837$7.13$205.6KForm 4
MPM BIOVENTURES 2018, L.P.10 percent ownerSep 1, 2026SELL29,088$7.06$205.4KForm 4
MPM BIOVENTURES 2018, L.P.10 percent ownerSep 2, 2026SELL25,131$7.19$180.7KForm 4
MPM BIOVENTURES 2018, L.P.10 percent ownerSep 3, 2026SELL32,263$7.17$231.3KForm 4
MPM BioVentures 2014, L.P.10 percent ownerSep 1, 2026SELL29,088$7.06$205.4KForm 4
MPM BioVentures 2014, L.P.10 percent ownerSep 2, 2026SELL25,131$7.19$180.7KForm 4
MPM BioVentures 2014, L.P.10 percent ownerSep 3, 2026SELL32,263$7.17$231.3KForm 4
Doshi Dipaldirector, officer: CEOSep 2, 2026TAX W/H8,724$7.14$62.3KForm 4
Dowden Nathan JPresident & COOSep 2, 2026TAX W/H2,528$7.14$18.1KForm 4
Sethuraman NatarajanPresident, Research & Develop.Sep 2, 2026TAX W/H2,079$7.14$14.9KForm 4
WENTWORTH KORY JAMESChief Financial OfficerSep 2, 2026TAX W/H1,733$7.14$12.4KForm 4
MPM BIOVENTURES 2018, L.P.10 percent ownerAug 27, 2026SELL38,922$7.20$280.2KForm 4
MPM BIOVENTURES 2018, L.P.10 percent ownerAug 28, 2026SELL3,733$7.01$26.2KForm 4
MPM BIOVENTURES 2018, L.P.10 percent ownerAug 31, 2026SELL44,259$6.99$309.4KForm 4
MPM BioVentures 2014, L.P.10 percent ownerAug 27, 2026SELL38,922$7.20$280.2KForm 4
MPM BioVentures 2014, L.P.10 percent ownerAug 28, 2026SELL3,733$7.01$26.2KForm 4
MPM BioVentures 2014, L.P.10 percent ownerAug 31, 2026SELL44,259$6.99$309.4KForm 4
MPM BioVentures 2014, L.P.10 percent ownerAug 24, 2026SELL21,623$7.34$158.7KForm 4
MPM BioVentures 2014, L.P.10 percent ownerAug 25, 2026SELL26,522$7.54$200.0KForm 4
MPM BioVentures 2014, L.P.10 percent ownerAug 26, 2026SELL14,569$7.06$102.9KForm 4
MPM BIOVENTURES 2018, L.P.10 percent ownerAug 24, 2026SELL21,623$7.34$158.7KForm 4
MPM BIOVENTURES 2018, L.P.10 percent ownerAug 25, 2026SELL26,522$7.54$200.0KForm 4
MPM BIOVENTURES 2018, L.P.10 percent ownerAug 26, 2026SELL14,569$7.06$102.9KForm 4
PARMAR KUSHdirectorAug 6, 2026SELL10,494$7.00$73.5KForm 4
PARMAR KUSHdirectorAug 7, 2026SELL52,317$6.85$358.4KForm 4
PARMAR KUSHdirectorAug 10, 2026SELL92,444$7.00$647.1KForm 4
5AM Ventures V, L.P.10 percent ownerAug 6, 2026SELL10,494$7.00$73.5KForm 4
5AM Ventures V, L.P.10 percent ownerAug 7, 2026SELL52,317$6.85$358.4KForm 4
5AM Ventures V, L.P.10 percent ownerJul 30, 2026SELL114,756$6.93$795.3KForm 4
5AM Ventures V, L.P.10 percent ownerJul 31, 2026SELL1,718$6.85$11.8KForm 4
PARMAR KUSHdirector, 10 percent owner: Jul 30, 2026SELL114,756$6.93$795.3KForm 4
PARMAR KUSHdirector, 10 percent owner: Jul 31, 2026SELL1,718$6.85$11.8KForm 4
PARMAR KUSHdirector, 10 percent owner: Jun 10, 2026AWARD19,000$5.97$113.4KForm 4
KIM PETER SdirectorJun 10, 2026AWARD19,000$5.97$113.4KForm 4
Chapman GinadirectorJun 10, 2026AWARD19,000$5.97$113.4KForm 4
Radhakrishnan MahadirectorJun 10, 2026AWARD19,000$5.97$113.4KForm 4
Thistle MarydirectorJun 10, 2026AWARD19,000$5.97$113.4KForm 4
Zeiher Bernhardt GdirectorJun 10, 2026AWARD19,000$5.97$113.4KForm 4
Zeiher Bernhardt GdirectorMay 20, 2026BUY5,000$5.86$29.3KForm 4
Sethuraman NatarajanPresident, Research & Develop.May 4, 2026SELL25,907$15.39$398.8KForm 4
Dowden Nathan JPresident & COOMay 4, 2026OPTION EX.15,000$1.74$26.1KForm 4
Dowden Nathan JPresident & COOMay 4, 2026SELL15,000$15.33$230.0KForm 4
Dowden Nathan JPresident & COOMay 4, 2026OPTION EX.15,000$1.74$26.1KForm 4
WENTWORTH KORY JAMESChief Financial OfficerApr 1, 2026SELL2,500$12.95$32.4KForm 4
Dowden Nathan JPresident & COOMar 9, 2026SELL3,116$13.02$40.6KForm 4
Dowden Nathan JPresident & COOMar 10, 2026SELL11,894$13.05$155.2KForm 4
WENTWORTH KORY JAMESChief Financial OfficerMar 9, 2026SELL5,089$13.00$66.2KForm 4
WENTWORTH KORY JAMESChief Financial OfficerMar 10, 2026SELL11,388$13.02$148.2KForm 4
WENTWORTH KORY JAMESChief Financial OfficerMar 4, 2026SELL7,988$12.25$97.9KForm 4
Doshi Dipaldirector, officer: CEOMar 1, 2026AWARD139,400——Form 4
Doshi Dipaldirector, officer: CEOMar 2, 2026TAX W/H9,869$11.66$115.1KForm 4
Doshi Dipaldirector, officer: CEOMar 3, 2026TAX W/H19,181$11.76$225.5KForm 4
Doshi Dipaldirector, officer: CEOMar 1, 2026AWARD208,000$11.93$2.5MForm 4
WENTWORTH KORY JAMESChief Financial OfficerMar 1, 2026AWARD44,600——Form 4
WENTWORTH KORY JAMESChief Financial OfficerMar 2, 2026TAX W/H2,939$11.66$34.3KForm 4
WENTWORTH KORY JAMESChief Financial OfficerMar 3, 2026TAX W/H5,712$11.76$67.2KForm 4
WENTWORTH KORY JAMESChief Financial OfficerMar 1, 2026AWARD66,600$11.93$794.5KForm 4
Dowden Nathan JPresident & COOMar 1, 2026AWARD55,800——Form 4
Dowden Nathan JPresident & COOMar 2, 2026TAX W/H7,223$11.66$84.2KForm 4
Dowden Nathan JPresident & COOMar 3, 2026TAX W/H14,038$11.76$165.0KForm 4
Dowden Nathan JPresident & COOMar 1, 2026AWARD83,200$11.93$992.6KForm 4
Sethuraman NatarajanPresident, Research & Develop.Mar 1, 2026AWARD55,800——Form 4
Sethuraman NatarajanPresident, Research & Develop.Mar 2, 2026TAX W/H3,898$11.66$45.4KForm 4
Sethuraman NatarajanPresident, Research & Develop.Mar 3, 2026TAX W/H7,577$11.76$89.1KForm 4
Sethuraman NatarajanPresident, Research & Develop.Mar 1, 2026AWARD83,200$11.93$992.6KForm 4
WENTWORTH KORY JAMESChief Financial OfficerNov 21, 2025SELL8,910$9.98$88.9KForm 4
BAKER BROS. ADVISORS LP10 percent ownerNov 20, 2025BUY13,082$9.07$118.7KForm 4
BAKER BROS. ADVISORS LP10 percent ownerNov 20, 2025BUY13,386$9.07$121.4KForm 4
BAKER BROS. ADVISORS LP10 percent ownerNov 20, 2025BUY1,186$9.07$10.8KForm 4
BAKER BROS. ADVISORS LP10 percent ownerNov 20, 2025BUY1,213$9.07$11.0KForm 4
PARMAR KUSHdirector, 10 percent owner: Nov 14, 2025SELL200,000$8.80$1.8MForm 4
5AM Ventures V, L.P.10 percent ownerNov 14, 2025SELL200,000$8.80$1.8MForm 4
BAKER BROS. ADVISORS LP10 percent ownerNov 12, 2025BUY11,494$7.95$91.4KForm 4
BAKER BROS. ADVISORS LP10 percent ownerNov 12, 2025BUY80,881$7.73$625.3KForm 4
BAKER BROS. ADVISORS LP10 percent ownerNov 11, 2025BUY30,879$7.54$232.8KForm 4
BAKER BROS. ADVISORS LP10 percent ownerNov 11, 2025BUY11,701$7.39$86.5KForm 4
BAKER BROS. ADVISORS LP10 percent ownerNov 10, 2025BUY2,947$7.22$21.3KForm 4
BAKER BROS. ADVISORS LP10 percent ownerNov 10, 2025BUY25,364$7.21$183.0KForm 4
BAKER BROS. ADVISORS LP10 percent ownerNov 12, 2025BUY1,040$7.95$8.3KForm 4
BAKER BROS. ADVISORS LP10 percent ownerNov 12, 2025BUY7,321$7.73$56.6KForm 4
BAKER BROS. ADVISORS LP10 percent ownerNov 11, 2025BUY2,795$7.54$21.1KForm 4
BAKER BROS. ADVISORS LP10 percent ownerNov 11, 2025BUY1,059$7.39$7.8KForm 4
BAKER BROS. ADVISORS LP10 percent ownerNov 10, 2025BUY267$7.22$1.9KForm 4
BAKER BROS. ADVISORS LP10 percent ownerNov 10, 2025BUY2,296$7.21$16.6KForm 4
Doshi Dipaldirector, officer: CEOSep 2, 2025TAX W/H8,723$5.43$47.4KForm 4
Dowden Nathan JPresident & COOSep 2, 2025TAX W/H1,746$5.43$9.5KForm 4
Sethuraman NatarajanPresident, Research & Develop.Sep 2, 2025TAX W/H1,760$5.43$9.6KForm 4
WENTWORTH KORY JAMESChief Financial OfficerSep 2, 2025TAX W/H1,734$5.43$9.4KForm 4
PARMAR KUSHdirector, 10 percent owner: Jul 9, 2025SELL20,065$7.50$150.5KForm 4
PARMAR KUSHdirector, 10 percent owner: Jul 9, 2025SELL6,935$7.50$52.0KForm 4
5AM Ventures V, L.P.10 percent ownerJul 9, 2025SELL20,065$7.50$150.5KForm 4
5AM Ventures V, L.P.10 percent ownerJul 9, 2025SELL6,935$7.50$52.0KForm 4
PARMAR KUSHdirector, 10 percent owner: Jun 27, 2025SELL55,735$6.91$385.1KForm 4
PARMAR KUSHdirector, 10 percent owner: Jun 30, 2025SELL18,578$6.81$126.6KForm 4
PARMAR KUSHdirector, 10 percent owner: Jul 1, 2025SELL18,578$7.12$132.3KForm 4